Uptake and biodisposition of 2-ylcyanamide-1,3,4-thiadiazole (LY217896) by red blood cells
✍ Scribed by Peter L Bonate; Albert Peyton
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 862 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
✦ Synopsis
In man, I4C-2-ylcyanamide-l 3 4-thiadiazole (LY217896) accumulates into red blood cells (RBCs) where it is rapidly metabolized. Both in man and ex vivo, within a few hours of administration of 14C-LY21 7896 at least two intracellular metabolites were detected within the RBCs using HPLC. These metabolites were never detected extracellularly. After 24 h no detectable radioactivity was found in the plasma and all the radioactivity was detected within the cellular fraction. All radioactivity was identified as a single peak within the RBCs, indicating the metabolite(s) to be highly polar compared to LY217896. Parent LY217896 was never detected within the RBCs at any time point, suggesting transport, either by diffusion or a carrier mediated mechanism, was the rate limiting step. Due to the nature of the preparation it was impossible to separately characterize uptake and biotransformation. Nevertheless, uptake/biotransformation was found to be temperature sensitive, sodium independent, and energy dependent. Both niacin and vitamin B6, but not nicotinamide, competitively blocked the uptake and subsequent intracellular metabolism of LY2 17896.
📜 SIMILAR VOLUMES
## Abstract The red blood cell (RBC) uptake of rubidium‐86 (Rb‐86), a sensitive in vitro test of RBC membrane transport, was measured in 22 controls, 8 patients with benign breast lesions, and 30 stage I/II, 13 stage III/IV untreated breast cancers. Total Rb‐86 transport was measured. Following oua
## Abstract Red blood cells (RBCs) are prone to lipid peroxidation by virtue of their function as oxygen carriers, and also because of their lipid composition. Malondialdehyde (MDA) content using thiobarbituric reagent is widely used to quantify lipid peroxidation. In this study we compare MDA assa
## Abstract The effects of LY‐171883, an orally active leukotriene antagonist, on membrane currents were examined in pituitary GH~3~ and in neuroblastoma IMR‐32 cells. In GH~3~ cells, LY‐171883 (1–300 μM) reversibly increased the amplitude of Ca^2+^‐activated K^+^ current in a concentration‐depende